(Q44187376)

30 November 2017

3HMK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

6 December 2022

1 reference

3

Agid Y

1 reference

30 November 2017

S. Holemans

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837752

6 December 2022

F. Javoy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837752

6 December 2022

E. C. Laterre

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837752

6 December 2022

J. M. Maloteaux

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837752

6 December 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

30 November 2017

22 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1837752

full work available at URL

6 December 2022

https://api.elsevier.com/content/article/PII:000689939191747O?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

https://api.elsevier.com/content/article/PII:000689939191747O?httpAccept=text/plain

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

6 December 2022

1 reference

30 November 2017

565

1 reference

30 November 2017

154-157

1 reference

30 November 2017

1

1 reference

Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease

30 November 2017

2

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

6 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

6 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

6 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

6 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

6 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

6 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Excitatory amino acid receptors in the vertebrate central nervous system

6 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Selective sparing of a class of striatal neurons in Huntington's disease

6 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy

6 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Excitatory amino acid antagonists and Parkinson's disease

6 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Synaptic localization of striatal NMDA, quisqualate and kainate receptors

6 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

6 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Protein measurement with the Folin phenol reagent

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Excitatory amino acids and neuropsychiatric disorders

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man.

6 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Effects ofl-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices

6 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions

6 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

6 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

6 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

6 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

NMDA receptor losses in putamen from patients with Huntington's disease

6 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91747-O

6 December 2022

Identifiers

1 reference

30 November 2017

1 reference